Scribd Logo
Upload

Welcome to Scribd!

  • 31 views

    Merck & Co Inc (MRK US) - As Reported

    Uploaded by

    Guillermo Roman Tager
    This document provides financial information for Merck & Co for fiscal years 2007 through 2016. It includes details on cash flows from operating, investing and financing activities. Key line items include net income, depreciation and amortization, capital expenditures, purchases and sales of investments, dividends paid, and changes in short and long term debt. Overall cash flows from operations ranged from approximately $7 billion to $13 billion over the period reported.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd

    Merck & Co Inc (MRK US) - As Reported

    Uploaded by

    Guillermo Roman Tager
    31 views6 pages
    This document provides financial information for Merck & Co for fiscal years 2007 through 2016. It includes details on cash flows from operating, investing and financing activities. Key line items include net income, depreciation and amortization, capital expenditures, purchases and sales of investments, dividends paid, and changes in short and long term debt. Overall cash flows from operations ranged from approximately $7 billion to $13 billion over the period reported.

    Original Description:

    CashFlowMerk

    Original Title

    CahsFlowMerk

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document provides financial information for Merck & Co for fiscal years 2007 through 2016. It includes details on cash flows from operating, investing and financing activities. Key line items include net income, depreciation and amortization, capital expenditures, purchases and sales of investments, dividends paid, and changes in short and long term debt. Overall cash flows from operations ranged from approximately $7 billion to $13 billion over the period reported.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    31 views6 pages

    Merck & Co Inc (MRK US) - As Reported

    Uploaded by

    Guillermo Roman Tager
    This document provides financial information for Merck & Co for fiscal years 2007 through 2016. It includes details on cash flows from operating, investing and financing activities. Key line items include net income, depreciation and amortization, capital expenditures, purchases and sales of investments, dividends paid, and changes in short and long term debt. Overall cash flows from operations ranged from approximately $7 billion to $13 billion over the period reported.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    of 6

    Merck & Co Inc (MRK US) - As Reported

    In Millions of USD except Per Share FY 2007 FY 2008


    12 Months Ending 12/31/2007 12/31/2008
    Cash Flow
    Cash From Operating Activities
    Change In Other Liabilites 26.2 -108.0
    Other Non-Cash Items 1,997.2 -1,491.0
    Change in Inventories -40.7 -452.1
    Change in Accounts Payable 117.7
    Change in Accounts Receivable -290.7 -889.4
    Equity In Earnings Of Affiliates/JV-CF -490.9 1,729.0
    Acquired In-Process R&D -CF 325.1
    Change in Accrued Expenses 451.1 -1,710.9
    Change in Income Taxes Payable (Receivable) 987.2 -465.3
    Impairments
    Total Cash Flows From Operations 6,999.2 6,571.7
    Gain/(Loss) On Early Extinguishment of Debt
    Gain (Loss) On Sale of Investments and Mkt Sec
    Change In Other Assets And Liabilities 105.1 -358.3
    Change in Other Current Assets and Liabilities
    Net Income - CF 3,275.4 7,808.4
    Depreciation And Amortization - CF 1,988.2 1,631.2
    Deferred Income Taxes - CF -1,781.9 530.1
    Stock Based Compensation 330.2 348.0
    Cash From Investing Activities
    Purchases of Investments -10,132.7 -11,967.3
    Divestiture of Business
    Acquisition of Business -1,135.9
    Capital Expenditures -1,011.0 -1,298.3
    Proceeds From Investments 10,860.2 11,065.8
    Other Investing Activities -1,390.6 365.4
    Proceeds From Short-Term Investments
    Total Cash Flows From Investing -2,810.0 -1,834.4
    Cash from Financing Activities
    Dividends Paid -3,307.3 -3,278.5
    Increase (Decrease) Short-Term Borrowings -Net 11.4 1,859.9
    Increase In Long-Term Borrowings
    Decrease In Long-Term Borrowings -1,195.3 -1,392.0
    Increase (Decrease) Long-Term Borrowings - Net
    Effect of Exchange Rates On Cash 98.3 -182.6
    Debt Financing/Issuance Costs
    Other Financing Activities 156.2 -89.2
    Cash Paid For Taxes 1,800.0
    Cash Paid For Interest 247.0
    Exercise of Stock Options 898.6 102.3
    Net Change In Cash -578.6 -967.8
    Purchase of Treasury Stock -1,429.7 -2,725.0
    Cash and Cash Equivalents (End of Period) 5,336.1 4,368.3
    Cash and Cash Equivalents (Beg of Period) 5,914.7 5,336.1
    Total Cash Flows From Financing -4,866.1 -5,522.5
    Reference Items
    Cash Paid For Taxes 3,500.0 1,800.0
    Cash Paid For Interest 406.4 247.0
    Source: Bloomberg
    FY 2009 FY 2010 FY 2011 FY 2012 FY 2013
    12/31/2009 12/31/2010 12/31/2011 12/31/2012 12/31/2013

    231.3 -98.0 -7.0 -1,747.0 -132.0


    -11,226.3 -226.0 323.0 28.0 399.0
    1,211.3 1,990.0 -678.0 -482.0 -365.0
    -45.2 124.0 182.0 -302.0 522.0
    165.2 -1,089.0 -1,168.0 349.0 436.0
    -510.7 -263.0 -394.0 -351.0 -167.0

    -4,003.5 35.0 1,444.0 -717.0 -397.0
    -364.8 128.0 -277.0 -34.0 -1,421.0
    2,441.0 705.0 200.0 765.0
    3,392.0 10,822.0 12,383.0 10,022.0 11,654.0

    -136.0 0.0 0.0
    98.8
    -262.0 -1,203.0 563.0
    13,024.2 982.0 6,392.0 6,299.0 4,517.0
    2,576.0 7,381.0 7,427.0 6,978.0 6,988.0
    1,820.2 -1,092.0 -1,537.0 669.0 -330.0
    415.5 509.0 369.0 335.0 276.0

    -3,070.8 -7,197.0 -7,325.0 -12,841.0 -17,991.0


    323.0 0.0 46.0
    -12,972.6 -256.0 -373.0 0.0 -246.0
    -1,460.6 -1,678.0 -1,723.0 -1,954.0 -1,548.0
    10,941.9 4,561.0 6,149.0 7,783.0 16,298.0
    9,718.1 1,073.0 -116.0 207.0 293.0
    175.0 0.0 0.0
    3,156.0 -3,497.0 -2,890.0 -6,805.0 -3,148.0

    -3,479.1 -4,853.0 -4,811.0 -5,236.0 -5,277.0


    -2,422.0 90.0 1,076.0 624.0 -159.0

    -25.3 -1,341.0 -1,547.0 -22.0 -1,775.0
    4,228.0 1,999.0
    33.4 -295.0 42.0 -30.0 -346.0
    2,562.0 6,467.0
    -126.3 -106.0 -22.0 86.0 60.0


    186.4 363.0 321.0 1,310.0 1,210.0
    4,943.1 1,589.0 2,631.0 -80.0 2,170.0
    -1,593.0 -1,921.0 -2,591.0 -6,516.0
    9,311.4 10,900.0 13,531.0 13,451.0 15,621.0
    4,368.3 9,311.0 10,900.0 13,531.0 13,451.0
    -1,638.3 -5,441.0 -6,904.0 -3,267.0 -5,990.0

    957.5 1,600.0 2,700.0 2,500.0 2,300.0


    351.4 763.0 600.0 898.0 922.0
    FY 2014 FY 2015 FY 2016
    12/31/2014 12/31/2015 12/31/2016

    190.0 -277.0
    -12,045.0 2,313.0
    79.0 805.0
    593.0 -37.0
    -554.0 -480.0
    -72.0 -155.0

    1,635.0 -8.0
    -21.0 -266.0
    1,222.0 162.0
    7,860.0 12,421.0
    628.0 0.0


    -98.0 -5.0
    11,934.0 4,459.0 5,691.0
    6,691.0 6,375.0
    -2,600.0 -764.0
    278.0 299.0

    -24,944.0 -16,681.0
    15,120.0 316.0
    -4,881.0 -7,744.0
    -1,317.0 -1,283.0
    15,114.0 20,413.0
    534.0 221.0

    -374.0 -4,758.0

    -5,247.0 -5,117.0
    -460.0 -1,540.0
    3,146.0 7,938.0
    -6,617.0 -2,906.0

    -553.0 -1,310.0

    208.0 56.0


    1,560.0 485.0
    -8,180.0 1,083.0
    -7,703.0 -4,186.0
    7,441.0 8,524.0
    15,621.0 7,441.0
    -15,113.0 -5,270.0

    7,900.0 1,800.0
    852.0 653.0

    You might also like